Fundraising Fox

Aspen Neuroscience

<UNKNOWN>, US · 7 known investors

aspenneuroscience.com ↗

Aspen Neuroscience develops iPSC-derived autologous cell therapies for neurological diseases, with a lead product (ANPD001) in Phase 1/2a clinical trials for Parkinson's disease. The company is a clinical-stage biotechnology firm focused on personalized neuron replacement therapies.

BiotechDeep TechDigital HealthMedical Devices

Founders & leadership

AB
Andrés Bratt-LealCo-Founder and Senior Vice President, Research & Development
DM
Damien McDevittPresident and Chief Executive Officer

Investors · 7

ARCH Venture Partners✓ verifiedChicago
Lifeforce Capital✓ verifiedChevy Chase
OrbiMed✓ verifiedNew York
Domain Associates✓ verifiedPrinceton
Section 32✓ verified
Medical Excellence Capital
S32reportedPalo Alto

In the news